cAMP drug
Evidence from:
primary |
all sources
Related entities (1)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| cAMP | regulates | gene expression | — | 1 |
Mentioned in (7)
Papers in which this entity is mentioned.
- ENPP1 Immunobiology as a Therapeutic Target. (2023)
- Human 3D brain organoids: steering the demolecularization of brain and neurological diseases. (2023)
- Transcriptomic analyses of gastrulation-stage mouse embryos with differential susceptibility to alcohol. (2021)
- Effects of chronic intermittent ethanol exposure and withdrawal on neuroblastoma cell transcriptome. (2020)
- Cannabinoids Exacerbate Alcohol Teratogenesis by a CB1-Hedgehog Interaction. (2019)
- Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy. (2019)
- Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells. (2016)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| camp | drug | 75 | 198 |
| cyclic adenosine 3′,5′-monophosphate | drug | — | — |
| cyclic adenosine monophosphate | drug | — | — |